BioXcel Therapeutics Inc (NASDAQ:BTAI)

14.27
Delayed Data
As of Jul 01
 +1.07 / +8.11%
Today’s Change
8.80
Today|||52-Week Range
36.49
-29.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.000.001.0K17.0K
 
 
 
 
Operating ExpensesGross Income0.000.00-1.0K-17.0K
 
 
 
General Expenses636.0K2.1M4.5M19.9M
 
 
 
 
 
Research And Development233.0K1.4M2.7M14.6M
 
 
 
 
 
Total Operating Expenses636.0K2.1M4.5M20.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-636.0K-2.1M-4.5M-20.0M
 
 
 
 
 
Interest Expense On Debt0.000.002.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-636.0K-2.1M-4.5M-19.3M
 
 
 
 
 
Net Income-636.0K-2.1M-4.5M-19.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.9M16.5M16.5M14.6M
 
 
 
 
 
Shares To Calculate EPS Diluted15.9M16.5M16.5M14.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.13-$0.28-$1.32
 
 
 
 
 
EPS Diluted-$0.04-$0.13-$0.28-$1.32